ALSEMPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ALSEMPHARMA
Largest movements
- Receivables within one year +€43,753
up €43,753 (+55.8%), from €78,392 to €122,145
of which Other amounts receivable: +€25,121
- Cash +€16,265
up €16,265 (+135.6%), from €11,997 to €28,262
mainly Debts after one year (+€101,049) and Short-term financial debts (+€100,000)
- Tangible fixed assets -€4,214
down €4,214 (-55.7%), from €7,561 to €3,347
of which Other tangible fixed assets: -€3,075
- Other debts -€101,110
down €101,110 (-96.2%), from €105,113 to €4,004
- Debts after one year +€101,049
new in 2025: €101,049
- Short-term financial debts +€100,000
new in 2025: €100,000
- Profit (loss) carried forward -€47,740
down €47,740 (-58.8%), from -€81,180 to -€128,919
- Trade debts -€19,868
down €19,868 (-11.6%), from €171,500 to €151,632
- Gross operating margin -€28,715
down €28,715 (-12.7%), from €225,292 to €196,577
- Other operating charges +€7,149
up €7,149 (+1111.6%), from €643 to €7,792
- Financial charges +€6,222
up €6,222 (+177.8%), from €3,499 to €9,721
- Financial income +€3,563
up €3,563 (+3333.7%), from €107 to €3,670
- Staff costs -€3,031
down €3,031 (-1.3%), from €230,262 to €227,231
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €284,615 | €336,894 | +€52,279 | +18.4% |
| Fixed assets | 21/28 | €7,561 | €3,347 | -€4,214 | -55.7% |
| Tangible fixed assets | 22/27 | €7,561 | €3,347 | -€4,214 | -55.7% |
| Land and buildings | 22 | €226 | €151 | -€75 | -33.3% |
| Plant, machinery and equipment | 23 | €4,260 | €3,196 | -€1,064 | -25.0% |
| Other tangible fixed assets | 26 | €3,075 | - | -€3,075 | |
| Current assets | 29/58 | €277,054 | €333,547 | +€56,493 | +20.4% |
| Stocks and contracts in progress | 3 | €180,331 | €177,458 | -€2,872 | -1.6% |
| Stocks | 30/36 | €180,331 | €177,458 | -€2,872 | -1.6% |
| Amounts receivable within one year | 40/41 | €78,392 | €122,145 | +€43,753 | +55.8% |
| Trade receivables | 40 | €70,691 | €89,323 | +€18,632 | +26.4% |
| Other amounts receivable | 41 | €7,701 | €32,822 | +€25,121 | +326.2% |
| Cash at bank and in hand | 54/58 | €11,997 | €28,262 | +€16,265 | +135.6% |
| Deferred charges and accrued income | 490/1 | €6,335 | €5,682 | -€653 | -10.3% |
| Total equity and liabilities | 10/49 | €284,615 | €336,894 | +€52,279 | +18.4% |
| Equity | 10/15 | -€19,206 | -€66,946 | -€47,740 | -248.6% |
| Contributions | 10/11 | €61,973 | €61,973 | = | 0.0% |
| Capital | 10 | €61,973 | €61,973 | = | 0.0% |
| Issued capital | 100 | €61,973 | €61,973 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€81,180 | -€128,919 | -€47,740 | -58.8% |
| Amounts payable | 17/49 | €303,821 | €403,840 | +€100,019 | +32.9% |
| Amounts payable after more than one year | 17 | - | €101,049 | +€101,049 | |
| Financial debts | 170/4 | - | €101,049 | +€101,049 | |
| Amounts payable within one year | 42/48 | €303,821 | €299,120 | -€4,701 | -1.5% |
| Current portion of amounts payable after more than one year | 42 | - | €3,951 | +€3,951 | |
| Financial debts | 43 | - | €100,000 | +€100,000 | |
| Credit institutions | 430/8 | - | €100,000 | +€100,000 | |
| Trade debts | 44 | €171,500 | €151,632 | -€19,868 | -11.6% |
| Suppliers | 440/4 | €171,500 | €151,632 | -€19,868 | -11.6% |
| Taxes, remuneration and social security | 45 | €27,208 | €39,534 | +€12,326 | +45.3% |
| Taxes | 450/3 | - | €12,444 | +€12,444 | |
| Remuneration and social security | 454/9 | €27,208 | €27,090 | -€118 | -0.4% |
| Other amounts payable | 47/48 | €105,113 | €4,004 | -€101,110 | -96.2% |
| Accrued charges and deferred income | 492/3 | - | €3,670 | +€3,670 | |
| Remuneration, social security and pensions | 62 | €230,262 | €227,231 | -€3,031 | -1.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,552 | €3,242 | -€309 | -8.7% |
| Other operating charges | 640/8 | €643 | €7,792 | +€7,149 | +1111.6% |
| Gross operating margin | 9900 | €225,292 | €196,577 | -€28,715 | -12.7% |
| Operating profit (loss) | 9901 | -€9,164 | -€41,688 | -€32,524 | -354.9% |
| Financial income | 75/76B | €107 | €3,670 | +€3,563 | +3333.7% |
| Recurring financial income | 75 | €107 | €3,670 | +€3,563 | +3333.7% |
| Financial charges | 65/66B | €3,499 | €9,721 | +€6,222 | +177.8% |
| Recurring financial charges | 65 | €3,499 | €9,721 | +€6,222 | +177.8% |
| Profit (loss) for the period before taxes | 9903 | -€12,557 | -€47,740 | -€35,183 | -280.2% |
| Profit (loss) for the period | 9904 | -€12,557 | -€47,740 | -€35,183 | -280.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€12,557 | -€47,740 | -€35,183 | -280.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.